Current senior management at KeyPlants were pioneers in bringing the

modular facility concept to the pharmaceutical industry

KeyPlants was founded in 2010. Our team has managed and executed

more than 220 modular and conventional projects in Sweden and

worldwide, for companies such as AstraZeneca, MSD, Eli Lilly, GSK B,

Teva, and Galderma. 

Many of our project managers and engineers have more than 20 years of

experience in pharmaceutical and process engineering and have

accumulated an impressive track record of successfully executed projects.